Antiphospholipid antibodies (aPL) increase the potential monocyte procoagulant activity in patients with systemic lupus erythematosus

F. Martini, A. Farsi, A. M. Gori, M. Boddi, S. Fedi, M. P. Domeneghetti, A. Passaleva, D. Prisco, R. Abbate

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Antiphospholipid antibodies (aPL) increase the potential monocyte procoagulant activity in patients with systemic lupus erythematosus'. Together they form a unique fingerprint.

Medicine & Life Sciences